Making CAFs more normal could be an attractive strategy; for example, treatment with vitamin D receptor ligands in pancreatic cancer reverted activated stellate cells into a quiescent state and controlled the disease’s progression [17,18]. This evidence concerns the gene VDR and familial pancreatic carcinoma.